Skip to Content

Join the 'Bipolar Disorder' group to help and get support from people like you.

Bipolar Disorder News

Related terms: Bipolar Affective Disorder, Bipolar Affective Mood Disorder, Bipolar I Disorder, Manic Depression, Manic Depressive Disorder, Manic Depressive Illness, Mood Disorder, Bipolar, Bipolar Depression, Ultra Rapid Cycling, Bipolar II Disorder

FDA Approves Abilify MyCite (aripiprazole) Pill with Sensor to Digitally Track if Patients Have Ingested Their Medication

Posted 14 Nov 2017 by Drugs.com

November 13, 2017 – The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. The system works by sending a message from the pill’s sensor to a wearable patch. The patch transmits the information to a mobile application so that patients can track the ingestion of the medication on their smart phone. Patients can also permit their caregivers and physician to access the information through a web-based portal. “Being able to track ingestion of medications prescribed for mental illness may be ... Read more

Related support groups: Depression, Bipolar Disorder, Abilify, Schizophrenia, Aripiprazole, Abilify Maintena, Abilify Discmelt, Abilify MyCite

FDA OKs First 'Digital Pill', Abilify Mycite, That Lets Doctors Know It's Been Taken

Posted 14 Nov 2017 by Drugs.com

TUESDAY, Nov. 14, 2017 – Offering both the promise of better patient compliance with health care, but also fears of a medical "Big Brother," a newly approved "digital pill" allows physicians to track whether or not it's been ingested by patients. The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder. As explained in an FDA news release, the pill contains a sensor that communicates with a wearable patch. This patch in turn sends signals to the patients' smartphone, telling them whether or not they've taken the pill, along with the pertinent dates and times. "Patients can also permit their caregivers and physician to access the information through a web-based portal," the FDA noted – opening the ... Read more

Related support groups: Bipolar Disorder, Abilify, Schizophrenia, Mania, Schizoaffective Disorder, Aripiprazole, Abilify Maintena, Aristada, Abilify Discmelt, Abilify MyCite

'Digital Pill' Tells Doctor When Patient Takes It

Posted 14 Nov 2017 by Drugs.com

TUESDAY, Nov. 14, 2017 – The first drug designed to alert a doctor when a patient takes the medication has been approved by the U.S. Food and Drug Administration. Abilify MyCite (aripiprazole with sensor) has an embedded sensor that sends a message to a wearable patch that the medication's been taken. This allows the patient and doctor to track the medication's use via smartphone. Abilify, first approved in 2012, is now OK'd to treat schizophrenia, manic depression and bipolar disorder, the FDA said in a news release. "Being able to track ingestion of medications prescribed for mental illness may be useful for some patients," said Dr. Mitchell Mathis, director of the agency's Division of Psychiatry Products. Abilify MyCite hasn't been proven to improve patient compliance with taking medication on a prescribed schedule, the FDA stressed. And the drug shouldn't be used in an attempt to ... Read more

Related support groups: Depression, Bipolar Disorder, Abilify, Schizophrenia, Schizoaffective Disorder, Aripiprazole, Abilify Maintena, Aristada, Abilify Discmelt, Abilify MyCite

Genes May Explain Why Some Don't Respond to Bipolar Drug

Posted 8 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 8, 2017 – In a finding that pulls the roots of two mental illnesses closer together, researchers say people with bipolar disorder that's resistant to the drug lithium have a high number of genes associated with schizophrenia. Since the 1950s, lithium has been widely used to treat bipolar disorder. The drug stabilizes mood swings – the highs and lows associated with the disorder – and reduces the risk of suicide. But nearly one-fourth of patients don't respond to the drug and about 30 percent have only a partial response. To learn more about why some don't respond to the treatment, researchers studied the genetics of more than 2,500 bipolar patients who were given lithium. "We found that patients clinically diagnosed with bipolar disorder who showed a poor response to lithium treatment all shared something in common: a high number of genes previously identified for ... Read more

Related support groups: Bipolar Disorder, Seroquel, Abilify, Lithium, Schizophrenia, Mania, Latuda, Risperidone, Zyprexa, Schizoaffective Disorder, Quetiapine, Risperdal, Geodon, Saphris, Seroquel XR, Olanzapine, Rexulti, Invega, Clozapine, Aripiprazole

Daily 'Light Therapy' May Help Some With Bipolar Disorder

Posted 12 Oct 2017 by Drugs.com

THURSDAY, Oct. 12, 2017 – People afflicted with bipolar disorder may find some relief from depression with daily doses of light therapy, new research suggests. With light therapy, people spend time sitting in close proximity to a light-emitting box – in this case, bright white light – with exposures increasing from 15 minutes per day to a full hour over a period of weeks. The study found that within a month the therapy helped treat depression in people with bipolar disorder. "Effective treatments for bipolar depression are very limited," noted lead researcher Dr. Dorothy Sit. "This gives us a new treatment option for bipolar patients that we know gets us a robust response within four to six weeks," said Sit, who is associate professor of psychiatry at Northwestern University in Chicago. According to the Brain & Behavior Research Foundation, bipolar disorder "is a brain and behavior ... Read more

Related support groups: Depression, Bipolar Disorder, Major Depressive Disorder, Mania, Zyprexa, Olanzapine, Dysthymia, Valproic Acid, Symbyax, Zyprexa Zydis, Severe Mood Dysregulation, Cyclothymic Disorder, Depakene, Fluoxetine/Olanzapine, Zyprexa Intramuscular, Stavzor, Depacon, Disruptive Mood Dysregulation Disorder, Zyprexa Relprevv

Americans More Open About Mental Health Issues, But Stigma Lingers

Posted 3 Oct 2017 by Drugs.com

TUESDAY, Oct. 3, 2017 – Americans may be more willing to talk about mental health issues these days, but misperceptions and stigmas persist, a new survey finds. The survey, of more than 3,000 U.S. adults, found that 70 percent said they feel people are more open to discussing mental health compared with a decade ago. Most respondents also said they'd want to help a family member or friend struggling with depression or other mental health conditions. On the other hand, age-old misperceptions were still common. Many people, for example, thought that mental health disorders were at least partially driven by "personal failings." "That's certainly disappointing," said Dr. Don Mordecai, director of mental health and addiction medicine services at Kaiser Permanente, in Oakland, Calif., which commissioned the poll. "These are true brain conditions," Mordecai said, "and we have to get away from ... Read more

Related support groups: Depression, Anxiety, Bipolar Disorder, Anxiety and Stress, Major Depressive Disorder, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, Schizophrenia, Paranoid Disorder, Schizoaffective Disorder, Dysthymia, Psychiatric Disorders, Severe Mood Dysregulation

Parents Say Schools Don't Help Kids With Mental Health, Chronic Disease

Posted 18 Sep 2017 by Drugs.com

MONDAY, Sept. 18, 2017 – Many parents don't believe schools are prepared to help students with mental health problems and serious physical health issues, a new survey finds. While 77 percent of parents were certain that schools would be able to provide first aid for minor issues such as cuts, they were less confident that schools could respond to more challenging health situations. For example, only 38 percent believed schools could assist a student suspected of having a mental health problem. The national poll on children's health was released Monday by the C.S. Mott Children's Hospital at the University of Michigan. "Parents feel schools can handle basic first aid, but are less sure about urgent health situations such as an asthma attack, epileptic seizure, or serious allergic reaction," Sarah Clark, poll co-director, said in a university news release. "And they have the most ... Read more

Related support groups: Depression, Anxiety, Bipolar Disorder, Anxiety and Stress, Major Depressive Disorder, Attention-Deficit Hyperactivity Disorder (ADHD), Schizophrenia, Borderline Personality Disorder, Oppositional Defiant Disorder, Psychiatric Disorders, Dysthymia, Anorexia, Aggressive Behavior

Health Tip: Mental Disorders Are Common

Posted 9 Aug 2017 by Drugs.com

-- More than 43 million American adults, 18 percent of the U.S. population, had a mental disorder in the past year, the most recent surveys cited by the Substance Abuse and Mental Health Services Administration (SAMHSA) show. These disorders – characterized by significant changes in mood, thoughts or behavior – often make carrying out daily activities more difficult and impair relationships with family and friends. If you or a loved one has a mental disorder, the agency suggests: Don't blame yourself or the person with the disorder. It's not an "attitude problem," but a medical condition. Listen to the person carefully, but don't judge him or her. Ask gently if you can make an appointment to see a health professional. The affected person may not be able to do this. As worried as you may be about the affected person, avoid the temptation to argue or convince the person of a problem. ... Read more

Related support groups: Depression, Anxiety, Bipolar Disorder, Panic Disorder, Anxiety and Stress, Major Depressive Disorder, Post Traumatic Stress Disorder, Social Anxiety Disorder, Schizophrenia, Mania, Borderline Personality Disorder, Eating Disorder, Psychosis, Psychiatric Disorders, Dysthymia

Abilify Maintena (aripiprazole) for Extended-Release Injectable Suspension Approved by the U.S. FDA for Maintenance Monotherapy Treatment of Bipolar I Disorder

Posted 8 Aug 2017 by Drugs.com

Valby, Denmark and Tokyo, Japan, 28 July 2017 - H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced Abilify Maintena® (aripiprazole) for extended-release injectable suspension was approved by the U.S. Food and Drug Administration for the maintenance monotherapy treatment of bipolar I disorder (BP I) in adults1. Abilify Maintena is a once-monthly injectable formulation for intramuscular use created by Otsuka and has been co-developed and co-commercialized with Lundbeck. Based on phase III study data, Abilify Maintena delayed the time to recurrence of any mood episode in adult patients experiencing a manic episode at screening compared to placebo1. "Bipolar I disorder is a recurrent chronic mental illness. Abilify Maintena provides healthcare professionals (HCPs) a new treatment option for their patients who have established tolerability with oral ... Read more

Related support groups: Bipolar Disorder, Abilify, Aripiprazole, Abilify Maintena

Nearly 1 in 5 U.S. Adults Has Mental Illness or Drug Problem

Posted 21 Jul 2017 by Drugs.com

FRIDAY, July 21, 2017 – Nearly 1 in 5 American adults deals with a mental illness or substance abuse problem each year, a U.S. government study says. Oregon has the highest rate, and New Jersey the lowest, according to 2012-2014 data analyzed by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA). Overall, almost 44 million Americans 18 or older had a diagnosable mental, behavioral or emotional disorder in the past year, researchers said. They reviewed national surveys on drug use and health. "The figures in SAMHSA's report remind us how important it is to take mental health as seriously as any other health condition," Kana Enomoto, SAMHSA acting deputy assistant secretary, said in an agency news release. The overall national rate of mental illness was about 18 percent. In Oregon, almost 23 percent of the state residents had any type of mental illness. Utah, ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Bipolar Disorder, Anxiety and Stress, Oxycodone, Tramadol, Hydrocodone, Methadone, Percocet, OxyContin, Vicodin, Major Depressive Disorder, Norco, Obsessive Compulsive Disorder, Fentanyl, Opiate Dependence, Morphine, Post Traumatic Stress Disorder, Codeine

Poor Sleep May Worsen Suicidal Thoughts

Posted 28 Jun 2017 by Drugs.com

WEDNESDAY, June 28, 2017 – Sleep problems may provide early clues about worsening suicidal thoughts in at-risk young adults as well as a potential way to intervene, a new study suggests. "Suicide is the tragic outcome of psychiatric illness interacting with multiple biological, psychological and social risk factors," said lead author Rebecca Bernert. She is a suicidologist and assistant professor of psychiatry and behavioral sciences from Stanford University Medical School. "Sleep disturbances stand apart from other risk factors because they are visible as a warning sign, yet non-stigmatizing and highly treatable. This is why we believe they may represent an important treatment target in suicide prevention," she said in a university news release. How could sleep potentially prevent a suicide? "Sleep is a barometer of our well-being, and directly impacts how we feel the next day. We ... Read more

Related support groups: Depression, Anxiety, Bipolar Disorder, Anxiety and Stress, Sleep Disorders, Insomnia, Major Depressive Disorder, Obsessive Compulsive Disorder, Fatigue, Post Traumatic Stress Disorder, Social Anxiety Disorder, Schizophrenia, Mania, Borderline Personality Disorder, Psychiatric Disorders, Dysthymia, Shift Work Sleep Disorder, Drowsiness, Hypersomnia, Severe Mood Dysregulation

Study Cites Top Reasons Young Autism Patients Are Hospitalized

Posted 16 Jun 2017 by Drugs.com

FRIDAY, June 16, 2017 – Having a mood disorder significantly boosts the odds that young people with autism will be hospitalized for psychiatric care, according to a new study. People with autism are often hospitalized when their behavior problems overwhelm their caregivers, the study authors said. "The demand is far greater than the number of clinicians, the number of programs and the number of beds we have," said study leader Giulia Righi. She is an assistant professor of psychiatry and human behavior research at Brown University's Warren Alpert Medical School. Righi's team reviewed records of 473 people with autism, aged 4 to 20. The risk of hospitalization was seven times higher for those with a mood disorder. In addition, sleep problems more than doubled the chances of a hospital stay. And those with high scores on a scale of autism symptom severity had a slightly increased risk, ... Read more

Related support groups: Depression, Bipolar Disorder, Sleep Disorders, Insomnia, Fatigue, Social Anxiety Disorder, Mania, Borderline Personality Disorder, Autism, Psychiatric Disorders, Asperger Syndrome, Body Dysmorphic Disorder, Severe Mood Dysregulation, Cyclothymic Disorder, Disruptive Mood Dysregulation Disorder

Heart Risks to Fetus From Bipolar Drug May Be Lower Than Thought

Posted 8 Jun 2017 by Drugs.com

THURSDAY, June 8, 2017 – Lithium, a drug commonly used to treat bipolar disorder, is linked to an increased risk of heart malformations in babies born to women taking the drug during pregnancy. But new research says the risk is smaller than once believed. In a study of more than 1 million pregnant women, researchers found that those who took lithium during the first trimester of pregnancy had a twofold increase in the risk of heart malformations compared to women who didn't take the drug. That works out to about 1 additional case of heart problems per 100 births, the researchers said. "This association was dose dependent," said lead researcher Dr. Elisabetta Patorno, an assistant professor of medicine at Harvard Medical School. The higher the dose of the drug, the greater the chance of heart malformations, the researchers said. "The size of the association was substantially smaller ... Read more

Related support groups: Bipolar Disorder, Lithium, Mania, Cyclothymic Disorder, Severe Mood Dysregulation, Eskalith, Lithobid, Eskalith-CR, Disruptive Mood Dysregulation Disorder, Lithonate, Labor and Delivery including Augmentation, Lithotabs

Chronic Pain Common in Adults With Depression, Anxiety

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Chronic pain afflicts about half of adults who have anxiety or depression, a new study finds. More than 5,000 adults in Brazil diagnosed with anxiety or mood disorders such as depression and bipolar disorder were asked about other health problems. Among those with a mood disorder, half reported chronic pain; 33 percent, respiratory diseases; 10 percent, heart disease; 9 percent, arthritis; and 7 percent, diabetes. Among those with anxiety, 45 percent reported chronic pain; 30 percent, respiratory diseases; and 11 percent each for arthritis and heart disease. Adults with two or more chronic diseases had an increased risk of a mood or anxiety disorder. High blood pressure was associated with both disorders at 23 percent, according to the Columbia University study published online June 1 in the Journal of Affective Disorders. Senior author Dr. Silvia Martins said ... Read more

Related support groups: Pain, Depression, Anxiety, Generalized Anxiety Disorder, Bipolar Disorder, Suboxone, Anxiety and Stress, Oxycodone, Lexapro, Zoloft, Tramadol, Cymbalta, Hydrocodone, Methadone, Percocet, Effexor, Prozac, OxyContin, Vicodin, Major Depressive Disorder

Women Aren't Better at Reading People's Faces After All

Posted 19 May 2017 by Drugs.com

FRIDAY, May 19, 2017 – When it comes to spotting a familiar face, men are just as gifted as women, a new study suggests. The finding contradicts the widely held belief that women are better at recognizing faces and reading facial expressions than men are, the Penn State researchers said. "There has been common lore in the behavioral literature that women do better than men in many types of face-processing tasks, such as face recognition and detecting and categorizing facial expressions, although, when you look in the empirical literature, the findings are not so clear-cut," said researcher Suzy Scherf. She is an assistant professor of psychology and neuroscience. "I went into this work fully expecting to see an effect of biological sex on the part of the observer in facial recognition – and we did not find any. And we looked really hard," she added in a Penn State news release. Facial ... Read more

Related support groups: Depression, Generalized Anxiety Disorder, Bipolar Disorder, Social Anxiety Disorder, Schizophrenia, Paranoid Disorder, Schizoaffective Disorder, Dysthymia, Psychiatric Disorders, Diagnosis and Investigation

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Mania, Cyclothymic Disorder, Severe Mood Dysregulation, Disruptive Mood Dysregulation Disorder, Psychiatric Disorders

Related Drug Support Groups

gabapentin, Seroquel, clonazepam, citalopram, sertraline, Lamictal, Abilify, bupropion, lithium, view more... venlafaxine, Depakote, escitalopram, Latuda, lamotrigine, topiramate, clonidine, risperidone, Zyprexa, quetiapine, Risperdal, Geodon, Saphris, Seroquel XR, duloxetine, verapamil, carbamazepine, olanzapine, Depakote ER, levetiracetam, oxcarbazepine, aripiprazole, divalproex sodium, Vraylar, valproic acid, desvenlafaxine, Symbyax, armodafinil, perphenazine, ziprasidone, paliperidone, Zyprexa Zydis, Depakote Sprinkles, asenapine, Eskalith, Lithobid, Risperdal Consta, Equetro, Eskalith-CR, lurasidone, iloperidone, Risperdal M-Tab, Zyprexa Intramuscular, Abilify Maintena, fluoxetine / olanzapine, Abilify Discmelt, Lithonate, Lamictal CD, Lamictal ODT, Lithotabs, cariprazine, tiagabine, Abilify MyCite